Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Lambertz, R; Hölscher, A H; Bludau, M; Leers, J M; Gutschow, C; Schröder, W (2016). Management of Tracheo- or Bronchoesophageal Fistula After Ivor-Lewis Esophagectomy. World Journal of Surgery, 40(7):1680-1687.

Drebber, U; Madeja, M; Odenthal, M; Wedemeyer, I; Mönig, S P; Brabender, J; Bollschweiler, E; Hölscher, A H; Schneider, P M; Dienes, H P; Vallböhmer, D (2011). β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis. International Journal of Colorectal Disease, 26(9):1127-1134.

Brabender, J; Arbab, D; Huan, X; Vallböhmer, D; Grimminger, P; Ling, F; Neiss, S; Bollschweiler, E; Schneider, P M; Hölscher, A H; Metzger, R (2009). Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Annals of Surgical Oncology, 16(5):1378-1383.

Hoffmann, A C; Kaifi, J T; Vallböhmer, D; Yekebas, E; Grimminger, P; Leers, J M; Izbicki, J R; Hölscher, A H; Schneider, P M; Metzger, R; Brabender, J (2009). Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. Journal of Surgical Oncology, 100(5):414-417.

Hoffmann, A C; Vallböhmer, D; Prenzel, K; Metzger, R; Heitmann, M; Neiss, S; Ling, F; Hölscher, A H; Schneider, P M; Brabender, J (2009). Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. Journal of Cancer Research and Clinical Oncology, 135(9):1231-1237.

Grimminger, P P; Stöhlmacher, J; Vallböhmer, D; Schneider, P M; Hölscher, A H; Metzger, R; Danenberg, P V; Brabender, J (2009). Prognostic significance and clinicopathological associations of COX-2 SNP in patients with nonsmall cell lung cancer. Journal of Oncology, 2009:139590.

Grimminger, P; Vallböhmer, D; Hoffmann, A; Schulte, C; Bollschweiler, E; Schneider, P M; Hölscher, A H; Metzger, R; Brabender, J (2009). Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer. Journal of Surgical Oncology, 100(6):447-451.

Koenig, A M; Prenzel, K L; Bogoevski, D; Yekebas, E F; Bubenheim, M; Faithova, L; Vashist, Y K; Gawad, K A; Baldus, S E; Pantel, K; Schneider, P M; Hölscher, A H; Izbicki, J R (2009). Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Annals of Surgical Oncology, 16(2):454-462.

Vallböhmer, D; Drebber, U; Schneider, P M; Baldus, S; Bollschweiler, E; Brabender, J; Warnecke-Eberz, U; Mönig, S; Hölscher, A H; Metzger, R (2009). Surviving expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. Journal of Surgical Oncology, 99(7):409-413.

Grimminger, P; Ling, F C; Neiss, S; Vallböhmer, D; Lurje, G; Schneider, P M; Hölscher, A H; Metzger, R; Brabender, J (2009). The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer. Anticancer Research, 29(4):1281-1286.

This list was generated on Sat Nov 18 02:04:55 2017 CET.